Phase III trial showed significant survival benefit over chemotherapy alone
News
MHRA nod for Moderna’s COVID-19 vaccine for 12- to 17- year-olds
UK regulator confirms vaccine is “safe and effective” in this age group
Pirfenidone could offer ‘viable’ heart failure treatment
NIHR trial shows the lung drug could treat heart failure patients
FDA fast tracks breast cancer candidate samuraciclib
Carrick Therapeutics’ oral CDK7 inhibitor may improve patient outcomes
GSK, CureVac’s COVID-19 vaccine candidate shows promise in preclinical study
Preclinical study shows high protective efficacy in primates for Beta, Delta and Lambda variants
Lebrikizumab shows improvements in late-stage eczema trial
Endpoints of improved skin clearance, itch and quality of life were met
FDA OK’s third dose of Moderna’s COVID-19 vaccine for immunocompromised
Recent trial showed improved immune response after third dose
Beckley Psytech raises £58m to advance psychedelic medicines pipeline
The funding will be used to complete an ongoing Phase Ib trial with low-dose psilocybin
Welireg approved in US for rare VHL-associated cancers
VHL is a rare genetic disease which puts patients at risk of developing benign blood vessel tumours and several cancers
Health Secretary asks CMA to review high cost of PCR travel tests
Sajid Javid has requested a rapid high-level review of the market for PCR travel tests
Moderna’s COVID-19 vaccine maintains antibodies to six months, study shows
Variants studied included Alpha, Beta, Gamma, Delta, Epsilon and Iota
FDA approval for Xywav for idiopathic hypersomnia in adults
First and only FDA-approved treatment for the neurological sleep disorder
Entry closing next month for the 2021 Communications Awards
The 2021 Communications Awards will be closing its doors for entry on the 10th of September.
FDA approves Keytruda plus Lenvima for advanced kidney cancer
Combination treatment reduced the risk of disease progression or death by 61% versus Sutent
US rejects AZ and FibroGen’s anaemia drug roxadustat
FDA has requested an additional clinical trial on the safety of roxadustat
